Contact this trialFirst, we need to learn more about you.
Histone Methyltransferase Inhibitor
CC-99282 + Anti-Lymphoma Agents for Non-Hodgkin's Lymphoma
Recruiting1 awardPhase 1 & 2
Toronto, Ontario
This trial is testing a new drug, CC-99282, for patients with certain types of lymphoma who haven't responded to other treatments. Researchers are finding the safest dose and checking if it works better alone or with other drugs.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.